Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes

International Archives of Medicine

Volumn 3, Issue 1, 2010, Pages

  Benavente, Lorena ^a   Calleja, Sergio ^a   De La Vega, Vanessa ^a   García, Jorge ^a   Lahoz, Carlos H ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOMYOPATHY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RECURRENT DISEASE; SECONDARY PREVENTION; URINARY TRACT HEMORRHAGE;

EID: 77953057588     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-3-8     Document Type: Article

References (28)

1. Cerebral events after diagnosis of mitral valve prolapse. JF Averinos RD Brown DA Foley V Nkomo G Petty C Scott M Enriquez-Sarano, A community-based study of incident and predictive factors. Stroke 2003 34 1339 1345
2. Atrial fibrillation as an independent risk factor for stroke: The Framingham study. PA Wolf RD Abbott WB Kannel, Stroke 1991 22 983 938 1866765
3. Stroke Prevention in Atrial Fibrillation Investigators. RG Hart JL Halperin LA Pearce DC Anderson RA Kronmal R McBride E Nasco DG Sherman RL Talbert JR Marler, Ann Intern Med 2003 138 831 838 12755555
4. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project). P Sandercock J Bamford M Dennis J Burn J Slattery L Jones S Boonyakarnkul C Warlow, BMJ 1992 305 1460 1465 10.1136/bmj.305.6867.1460 1493391
5. Stroke severity in atrial fibrillation: the Framingham Study. HJ Lin PA Wolf M Kelly-Hayes AS Beiser CS Kase EJ Benjamin RB D'Agostino, Stroke 1996 27 1760 1764 8841325
6. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Australian Stroke registry. C Steger A Pratter M Martinek-Bregel M Avanzini A Valentin J Slany C Stollberger, Eur Heart J 2004 25 1734 1740 10.1016/j.ehj.2004.06.030 15451152
7. Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease. JI Sage RL Van Uitert, Stroke 1983 14 537 540 6658928
8. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group, Lancet 1993 342 1255 1262 7901582
9. Epidemiology of ischemic stroke subtytpes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population based study. PL Kolominsky-Rabas M Weber O Gefeller B Neundoerfer PU Heuschmann, Stroke 2001 32 2735 2740 10.1161/hs1201.100209 11739965
10. Adecuacián de la profilaxis anticoagulante en pacientes con fibrilacián auricular. J García S Calleja V de la Vega L Benavente S Rodríguez CH Lahoz, Rev Neurol 2005 41 7 399 403 16193445
11. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. HP Adams BH Bendixen LJ Kappelle J Biller BB Love DL Gordon EE Marsh, TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 3 1993 24 35 41
12. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta analyses. RG Hart O Benavente R McBride LA Pearce, Ann Int Med 1999 131 492 501 10507957
13. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Atrial Fibrillation Investigators, Atrial fibrillation, Aspirin, Anticoagulation Study, Boston Area Anticoagulation Trial for Atrial Fibrillation Study, Arch Intern Med 1994 154 1449 1457 10.1001/archinte.154.13.1449 8018000
14. Effect of intensity of oral anticoagulation for stroke severity and mortality in atrial fibrillation. EM Hylec AS Go Y Chang NG Jensvold LE Henault JV Selby DE Singer, N. Engl. J. Med 2003 349 1019 1026 10.1056/NEJMoa022913 12968085
15. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. AF Investigators, Arch. Intern. Med 1997 157 1237 1240 10.1001/archinte.157.11.1237 9183235
16. Japan Atrial Fibrillation Stroke Trial Group. Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation. Japan atrial fibrillation stroke trial. H Sato K Ishikawa A Kitabatake S Ogawa Y Maruyama Y Yokota T Fukuyama Y Doi S Mochizuki T Izumi N Takekoshi K Yoshida K Hiramori H Origasa S Uchiyama M Matsumoto T Yamahuchi M Hori, Stroke 2006 37 447 451 10.1161/01.STR.0000198839.61112.ee 16385088
17. Temporal trenes in the use of anticoagulants among older adults with atrial fibrillation. NL Smith BM Psaty CD Furberg R White JAC Lima AB Newman TA Manolio, Arch Intern Med 1999 159 1574 1578 10.1001/archinte.159.14.1574 10421280
18. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med. TJ Bungard WA Ghali KK Teo FA McAlister RT Tsuyuki, 2000 160 41 46 10632303
19. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. BF Gage M Boechler AL Doggette G Fortune GC Flaker MW Rich MJ Radford, Stroke 2000 31 822 827 10753982
20. Translating the results of randomized trials into clinical practice. The challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation. EM Hylek J D'Antonio C Evans-Molina C Shea LE Henault S Regan, Stroke 2006 37 1075 1080 10.1161/01.STR.0000209239.71702.ce 16527999
21. Chest. GW Albers P Amarenco J Donald Easton RL Sacco P Teal, 2008 133 630 669 18767311
22. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. BF Gage E Birman-Deych R Kerzner MJ Radford DS Nilasena MW Rich, Am J Med 2005 118 6 612 617 10.1016/j.amjmed.2005.02.022 15922692
23. Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician. RD Lopes JP Piccini EM Hylek CB Granger JH Alexander, J Thromb Thrombolysis 2008 26 3 167 174 10.1007/s11239-008-0272-4 18807225
24. A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation). ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial Flutter, Circulation 2008 117 1101 1120 10.1161/CIRCULATIONAHA.107.187192 18283199
25. An Inconvenient Truth. M Gattellari J Worthington Zwar N Warfarin, Stroke 2009 40 5 7 10.1161/STROKEAHA.108.527903 18757283
26. Frequency and effect of optimal anticoagulation before onset of ischemic stroke in patients with known atrial fibrillation. B Indredavik G Rohweder S Lydersen, J Intern Med 2005 258 133 144 10.1111/j.1365-2796.2005.01512.x 16018790
27. For the American college of cardiology/American heart association/European society of cardiology: Guidelines for the management of patients with atrial fibrillation. V Fuster LE Ryden RW Asinger DS Cannom HJ Crijns RL Frye JL Halperin GN Kay WW Klein S Levy, J Am Coll Cardiol 2001 38 1231 1265 10.1016/S0735-1097(01)01587-X 11583910
28. Antithrombotic therapy in atrial fibrillation: The seventh ACCP conference on antithrombotic and thrombolytic therapy. DE Singer GW Albers JE Dalen AS Go JL Halperin WJ Manning, Chest 2004 126 429S 456S 10.1378/chest.126.3-suppl.429S 15383480